96688 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms Val-amino acid
Stereoisomer Conjugates of Dextrorphan
#2NOVEL PROCESSES FOR PREPARING CAMPTOTHECIN DERIVATIVES
#3AFFINITY ILLUDOFULVENE CONJUGATES
#4Drug-Conjugates, Conjugation Methods, And Uses Thereof
#5Anti-CD70 Antibody Drug Conjugates
#6BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#7AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDERECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#8CONJUGATES OF ANTIBODY AND FUNCTIONAL SUBSTANCE OR SALTS THEREOF, AND COMPOUNDS USED IN PRODUCTION OF THE SAME OR SALTS THEREOF
#9METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#10PROCESS FOR THE PREPARATION OF DRUG LINKER COMPOUNDS
#11LINKER COMPOUNDS COMPRISING AMIDE BONDS
#12BIOACTIVE CONJUGATE, PREPARATION METHOD THEREFOR AND USE THEREOF
#13Anti-CD70 antibody drug conjugates
#14a-CARBONYL ALKENYL ESTER PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#15Affinity illudofulvene conjugates
#16OLIGOPEPTIDE LINKER INTERMEDIATE AND PREPARATION METHOD THEREOF
#17ANTIBODY DRUG CONJUGATES HAVING LINKERS COMPRISING HYDROPHILIC GROUPS
#18DELIVERY SYSTEMS FOR CONTROLLED DRUG RELEASE
#19Plant virus particles for delivery of antimitotic agents
#20AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS
#21NOVEL LINKERS
#22METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID
#23PYRROLOBENZODIAZEPINE CONJUGATES
#24Heteroaryl sulfone-based conjugation handles, methods for their preparation, and their use in synthesizing antibody drug conjugates
#25SELF-STABILIZING LINKER CONJUGATES
#26Linker, Antibody-Drug Conjugate Including Same and Use Thereof
#27Drug-conjugates, conjugation methods, and uses thereof
#28BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#29Affinity illudofulvene conjugates
#30Bifunctional cytotoxic agents containing the CTI pharmacophore
#31Indole derivatives as estrogen receptor degraders
#32NMDA ANTAGONIST PRODRUGS
#33Plant virus particles for delivery of antimitotic agents
#34Prodrugs of fencamfamine
#35Process for the preparation of drug linker compounds
#36Bioactive molecule conjugate, preparation method and use thereof
#37Chemiluminescent probes for imaging/detection of proteases
#38Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#39N-acyldipeptide derivatives and their uses
#40Plant virus particles for delivery of antimitotic agents
#41Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#42MALT1 inhibitors and uses thereof
#43Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#44Anti-CD70 antibody drug conjugates
#45PYRROLOBENZODIAZEPINE CONJUGATES
#46Structure of GII.4 norovirus protease—design of broad-spectrum protease inhibitors
#47Cytotoxic tubulysin compounds for conjugation
#48Indole derivatives as estrogen receptor degraders
#49NMDA antagonist prodrugs
#50Dipeptide analogs as TGF-beta inhibitors
#51Alpha-Ketoamide Inhibitors Of Cysteine Proteases
#52Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
#53Immunoproteasome inhibitor analogs
#54Prodrugs of fencamfamine
#55Delivery systems for controlled drug release
#56Molecular gelators and uses thereof
#57Tricyclic prodrugs
#58Combination of N-acyldipeptide derivatives and retinol, and methods of use thereof
#59MALT1 inhibitors and uses thereof
#60Drug-conjugates, conjugation methods, and uses thereof
#61Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#62Compositions and methods for inhibition of bacterial infections in human endocervix
#63Plant virus particles for delivery of antimitotic agents
#64Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#65Cystargolide compounds and uses thereof
#66SELF-STABILIZING LINKER CONJUGATES
#67Benzodiazepine dimers, conjugates thereof, and methods of making and using
#68Carbazole compound having anti-virus activity
#69Method for preparing largazole analogs and uses thereof
#70HETEROARYLENE-BRIDGED BENZODIAZEPINE DIMERS, CONJUGATES THEREOF, AND METHODS OF MAKING AND USING
#71NMDA antagonist prodrugs
#72BIOLOGICALLY ACTIVE C-TERMINAL ARGININE-CONTAINING PEPTIDES
#73ALDEHYDE CAPTURE LIGATION TECHNOLOGY FOR SYNTHESIS OF AMIDE BONDS
#74Pyrrolobenzodiazepines and conjugates thereof
#75Benzodiazepine dimers, conjugates thereof, and methods of making and using
#76Smart Pro-Drugs of Serine Protease Inhibitors
#77Compositions and methods for treating colorectal cancer
#78HCV NS-3 serine protease inhibitors
#79Macrocyclic inhibitors of flaviviridae viruses
#80Antibody drug conjugates
#81AMINO ACID SALTS OF UNSATURATED FATTY ACIDS
#82Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#83N-acyldipeptide derivatives and their uses
#84Selective caspase inhibitors and uses thereof
#85Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#86Biologically active C-terminal arginine-containing peptides
#87Glycopeptide derivatives for the preservation and protection of biological materials and microorganisms
#88Tricyclic prodrugs
#89NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES
#90Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing
#91Benzothiophene derivatives as estrogen receptor inhibitors
#92Antibody drug conjugates (ADCs) with kinesin spindel protein (KSP)
#93Cytotoxic tubulysin compounds for conjugation
#94Bifunctional cytotoxic agents containing the CTI pharmacophore
#95Isoquinolidinobenzodiazepines
#96Maytansinoid derivatives with peptide linker and conjugates thereof
#97Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#98Prodrug derivatives of substituted triazolopyridines
#99Heteroarylene-bridged benzodiazepine dimers, conjugates thereof, and methods of making and using
#100AMORPHOUS FORMS OF DACLATASVIR DIHYDROCHLORIDE
#101Potent and Efficient Cytotoxic Peptides and Antibody-Drug Conjugates thereof and Their Synthesis
#102Energy transfer within pi-conjugated peptide heterostructures in aqueous environments
#103Tubulysin analogs and methods of making and use
#104PRO-DRUG COMPOUNDS
#105Cytotoxic and anti-mitotic compounds, and methods of using the same
#106Liquid automatic dish washing detergent compositions
#107Hepatitis C virus inhibitors
#108Estrogen-related receptor alpha based protac compounds and associated methods of use
#109Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#110Compounds for enzyme inhibition
#111Macrocyclic inhibitors of flaviviridae viruses
#112CRYSTALLINE POLYMORPHS
#113SELF-STABILIZING LINKER CONJUGATES
#114Macrocyclic inhibitors of flaviviridae viruses
#115Synthesis and intermediates of pyrrolobenzodiazepine derivatives for conjugation
#116N-acyldipeptide derivatives and their uses
#117NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME
#118Combinations of a caspase inhibitor and an antiviral agent
#119Aldehyde capture ligation technology for synthesis of amide bonds
#120Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
#121ANGIOTENSIN-CONVERTING-ENZYME INHIBITING DIPEPTIDE
#122Pharmaceutical composition for the prevention and treatment of cardiovascular disease comprising the peptide having the ability to inhibit angiotensin-1 converting enzyme as an active ingredient
#123Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
#1241-(chloromethyl)-2,3-dihydro-1H-benzo[E]indole dimer antibody-drug conjugate compounds, and methods of use and treatment
#125ANTI-VIRAL COMPOUNDS
#126Pyrrolobenzodiazepines as unsymmetrical dimeric PBD compounds for inclusion in targeted conjugates
#127Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
#128Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#129Anti-CD70 antibody drug conjugates
#130Polyconjugates for delivery of RNAi triggers to tumor cells in vivo
#131Compositions containing delta-9-THC-amino acid esters and process of preparation
#132Niacin-peptide having skin whitening activity and use for same
#133Selective caspase inhibitors and uses thereof
#134Hepatitis C virus inhibitors
#135Compositions and method for treatment of ischemic neuronal reperfusion injury
#136Stabilized subtilisin composition
#137N-acyldipeptide derivatives and their uses
#138Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
#139Compositions and methods for inhibiting proteases
#140Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#141BENZIMIDAZOLE ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS
#142Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#143Spiro compounds as Hepatitis C virus inhibitors
#144MODULATORS OF PHARMACOKINETIC PROPERTIES OF THERAPEUTICS
#145Amide derivatives of N-urea substituted amino acids as formyl peptide receptor like-1 (FPRL-1) receptor modulators
#146Bis(fluoroalkyl)-1,4-benzodiazepinone compounds and prodrugs thereof
#147Bisphosphonate-prodrugs
#148Macrocyclic inhibitors of flaviviridae viruses
#149Macrocyclic inhibitors of flaviviridae viruses
#1503-Amino-2-Hydroxy-4-Phenylbutanoyl-Valyl-Isoleucine, Preparation and Use Thereof
#151Macrocyclic inhibitors of flaviviridae viruses
#152Self-stabilizing linker conjugates
#153Hepatitis C virus inhibitors
#154Lipid dipeptide and gel
#155Inhibitors of HCV NS5A
#156NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOF
#157Compounds for enzyme inhibition
#158Compounds for enzyme inhibition
#159Compounds for enzyme inhibition
#160Maytansinoid derivatives with peptide linker and conjugates thereof
#161Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#162Macrocyclic inhibitors of flaviviridae viruses
#163Hepatitis C virus inhibitors
#164Multi-valent poly-Ubl chain inhibitors and methods of use
#165Peptidomimetic protease inhibitors
#166Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#167Method for preparing lipopeptide compound
#168Native chemical ligation at serine and threonine sites
#169Peptides for the Treatment of HCV Infections
#170INHIBITORS OF INTERLEUKIN-1 BETA CONVERTING ENZYME
#171Inhibitors of the trypsin-like site of the proteasome and methods of use thereof
#172Peptide for augmenting and expression of BDNF and pharmaceutical composition for prevention and treatment of neurodegenerative diseases including Alzheimer's disease or Parkinson's disease, comprising the same
#173Asymmetric synthesis of peptides
#174Peptide derivatives for treatment, prevention or alleviation of a condition associated with bone loss or low bone density or to inhibit osteoclast differentiation and stimulation
#175Compounds for enzyme inhibition
#176Peptidomimetic protease inhibitors
#177PURIFICATION OF AMPHOTERIC PRODUCTS, OR OF PRODUCTS LIABLE TO BE CONVERTED INTO AMPHOTERIC PRODUCTS
#178Hepatitis C virus inhibitors
#179Dipeptoid prodrugs and the use thereof
#180DEUTERATED COMPOUNDS AS HEPATITIS C VIRUS (HCV) INHIBITORS
#181ASYMMETRIC SYNTHESIS OF PEPTIDES
#182Modulators of pharmacokinetic properties of therapeutics
#1832-Aminocarbonyl Substituted Piperazine or Diaza-Cyclic Compounds as Apoptosis Protein Inhibitors (Iap) Modulators
#184Lipid dipeptide and gel
#185Biologically active C-terminal arginine-containing peptides
#186Benzimidazole analogues for the treatment or prevention of flavivirus infections
#187Flexibly labeling peptides
#188Selective caspase inhibitors and uses thereof
#189Mass- and property-tuned variable mass labeling reagents and analytical methods for simultaneous peptide sequencing and multiplexed protein quantification using thereof
#190Heterocyclic peptide ketoamides
#191Process for treating the skin comprising applying to the skin at least one composition comprising at least one N-aminoacylamide
#192Inhibitors of interleukin-1 beta converting enzyme
#193PEPTIDE COMPOUNDS FOR DETECTING OR INHIBITING SARS CORONAVIRUS AND APPLICATION THEREOF
#194COMPOUNDS FOR PREVENTING OR TREATING A VIRAL INFECTION
#195Peptide production and purification process
#196Heterocyclic self-immolative linkers and conjugates
#197Methods of treating drug-resistant cancers
#198Smart Pro-Drugs of Serine Protease Inhibitors
#199HCV NS-3 SERINE PROTEASE INHIBITORS
#200Chemical linkers and cleavable substrates and conjugates thereof
#201Compounds for enzyme inhibition
#202Compounds for enzyme inhibition
#203Prober cleaning block assembly
#204Peptidomimetic protease inhibitors
#205O-SUBSTITUTED HYDROXYARYL DERIVATIVES
#206Method for the synthesis of peptides without solvent
#207HCV NS-3 Serine Protease Inhibitors
#208Modulators of pharmacokinetic properties of therapeutics
#209AMINO ACID DERIVED PRODRUGS OF PROPOFOL, COMPOSITIONS AND USES THEREOF
#210Hepatitis C virus inhibitors
#211Phosphonyl ester conjugates as prodrugs
#212Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#213Tri-peptide Inhibitors of Serine Elastases
#214Stereochemically defined dipeptide esters of antiviral agents for enhanced ocular treatment
#215Biologically active C-terminal arginine-containing peptides
#216Acyclovir-peptide analogs
#217Heterocyclic self-immolative linkers and conjugates
#218Protease inhibitors for coronaviruses and SARS-CoV and the use thereof
#219Compounds of the N-acylamino amide family compositions comprising them and uses thereof
#220Asymmetric synthesis of peptides
#221Antibody-Drug Conjugates and Methods of Use
#222Hiv Prodrugs Cleavable by Cd26
#2232-aminocarbonyl substituted piperazine or diaza-cyclic compounds as apoptosis protein inhibitors (lap) modulators
#224Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid
#225Modulators of pharmacokinetic properties of therapeutics
#226Isoquinoline derivatives as calpain inhibitors
#227Flexibly labeling peptides
#228Inhibitors of interleukin-1β converting enzyme
#229Compounds for enzyme inhibition
#230Prodrugs cleavable by CD26
#231HCV NS-3 serine protease inhibitors
#232HCV NS-3 serine protease inhibitors
#233Advanced glycation end-product intermediaries and post-amadori inhibition
#234Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
#235Histone H2A peptide derivatives and uses thereof
#236Dipeptide phenyl ethers
#237Peptidyl allyl sulfones
#238Cosmetic compositions comprising N-acylamino amides
#239Hepatitis C virus inhibitors
#2402-hydroxytetrahydrofuran derivatives and use thereof as medicaments
#241Peptidyl prodrugs that resist P-glycoprotein mediated drug efflux
#242Cidofovir peptide conjugates as prodrugs
#243Amino acid derived prodrugs of propofol, compositions and uses thereof
#244O-substituted hydroxyaryl derivatives
#245Smart pro-drugs of serine protease inhibitors
#246Heterocyclic self-immolative linkers and conjugates
#247Novel compounds that inhibit tryptase activity
#248Derivatives of 2-hydroxytetrahydrofuran and their use as medicaments
#249Peptidomimetic protease inhibitors
#250Novel compounds of the N-acylamino amide family, compositions comprising them and uses thereof
#251Dipeptide phenyl ethers
#252Isotopically coded affinity markers 3
#253Acyclovir-peptide analogs
#254Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient